Browse Items (12 total)
- Tags: Community-Acquired Infections – Drug Therapy
International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.
Tags: 2003, Antibiotics, Clinical Trials, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Etiology, Department of Internal Medicine, Drug Resistance, Drugs, File T M Jr, Immune System – Drug Effects, Inpatients, Macrolide – Pharmacodynamics, Macrolide – Therapeutic Use, Methicillin Resistance, Microbial, NEOMED College of Medicine, Nonexperimental Studies, Outpatients, Pneumonia – Drug Therapy, Pneumonia – Etiology, Practice Guidelines, Risk Assessment, Streptococcal Infections – Drug Therapy, Tan J S
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
Tags: 2004, Antibiotics, Antibiotics – Administration and Dosage, Antiinfective Agents, Bacterial – Drug Therapy, Blasi F, Canada, Chest, Chidiac C, Community-Acquired Infections – Drug Therapy, Comparative Studies, Department of Internal Medicine, Drug Resistance, Europe, File T M Jr, Fluoroquinolone – Therapeutic Use, Garau J, Klugman K, Lactam – Therapeutic Use, Lode H, Lonks JR, Macrolide – Therapeutic Use, Mandell L, Microbial, NEOMED College of Medicine, Pneumonia, Practice Guidelines, Ramirez J, United States, Yu V
Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
Tags: 2004, Antibiotics, Bacteria – Drug Effects, Benninger MS, Clinics in laboratory medicine, Combined – Therapeutic Use, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Department of Internal Medicine, Drug Resistance, File T M Jr, Jacobs MR, Microbial, Microbial Culture and Sensitivity Tests, NEOMED College of Medicine, Pneumonia – Drug Therapy, Pneumonia – Microbiology, Rhinosinusitis – Drug Therapy, Rhinosinusitis – Microbiology
Community-acquired pneumonia.
Tags: 2003, Antibiotics – Therapeutic Use, Bacterial, Bacterial – Diagnosis, Bacterial – Drug Therapy, Bacterial – Microbiology, Bacterial – Prevention and Control, Community-Acquired Infections, Community-Acquired Infections – Diagnosis, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Community-Acquired Infections – Prevention and Control, Department of Internal Medicine, Disease Progression, Drug Resistance, File T M Jr, Immunocompetence, Lancet, Microbial, NEOMED College of Medicine, Pneumonia, Severity of Illness, Streptococcus – Drug Effects, Vaccines – Therapeutic Use
Community-acquired pneumonia: recent guidelines for therapy.
Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
Tags: 2004, Adult, Chi Square Test, Community-Acquired Infections – Drug Therapy, Current Medical Research & Opinion, Department of Internal Medicine, Double-Blind Studies, Female, File T M Jr, Funding Source, Human, Kaplan-Meier Estimator, Khashab MM, Log-Rank Test, Male, McNemar's Test, Milkovich G, NEOMED College of Medicine, Ofloxacin – Administration and Dosage, Pneumonia – Drug Therapy, Random Assignment, Retrospective Design, T-Tests, Tennenberg AM, Xiang JX, Zadeikis N
The Science of Selecting Antimicrobials for Community-Acquired Pneumonia (CAP)
Tags: 2009, Antibiotics, Antibiotics – Therapeutic Use, Antiinfective Agents, Bacterial – Drug Therapy, Combination, Community-Acquired Infections – Drug Therapy, Department of Internal Medicine, Drug Resistance, Drug Therapy, File T M, Gram-Negative Bacteria, Human, Journal of Managed Care Pharmacy, Lactam – Therapeutic Use, Legionnaires' Disease – Drug Therapy, Macrolide – Therapeutic Use, Microbial, Microbial Culture and Sensitivity Tests, NEOMED College of Medicine, Pneumonia, Practice Guidelines, Quinolone – Therapeutic Use, Streptococcus
Uncomplicated Pure Cellulitis: No Need to Cover for MRSA?
Tags: 2013, Antibiotics – Therapeutic Use, Cellulitis, Cellulitis – Diagnosis, Cellulitis – Drug Therapy, Cellulitis – Microbiology, Community-Acquired Infections – Drug Therapy, Department of Internal Medicine, Infectious Disease Alert, Methicillin-Resistant Staphylococcus aureus, NEOMED College of Medicine, Staphylococcal Infections – Drug Therapy, Streptococcal Infections – Drug Therapy, Treatment Outcomes, Watkins Richard R
Statin Use Is Associated With a Lower Risk of Community-acquired Staphylococcus aureus Bacteremia.
Tags: 2017, Bacteremia – Risk Factors, Biofilms – Drug Effects, Cell Physiology – Drug Effects, Community-Acquired Infections – Drug Therapy, Department of Internal Medicine, Drug Resistance, Infectious Disease Alert, Microbial, NEOMED College of Medicine, Neutrophils, Risk Assessment, Simvastatin – Administration and Dosage, Staphylococcus Aureus – Drug Effects, Statins – Economics, Statins – Therapeutic Use, Watkins Richard R
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
Tags: 2011, 80 and over, Aged, Bacteria, Bacteria/isolation & purification, Bacterial – Drug Therapy, Bacterial/*drug therapy, Ceftriaxone – Administration and Dosage, Ceftriaxone – Adverse Effects, Ceftriaxone/administration & dosage/adverse effects, Cephalosporins – Administration and Dosage, Cephalosporins – Adverse Effects, Cephalosporins/*administration & dosage/*adverse effects, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections/*drug therapy, Critchley Ian A, Department of Internal Medicine, Double-Blind Method, Double-Blind Studies, Eckburg Paul B, Female, File Thomas M Jr, Friedland H David, Human, Humans, Infusions, Intravenous, Lee Jon, Llorens Lily, Low Donald E, Male, Middle Age, Middle Aged, NEOMED College of Medicine, Pneumonia, RANDOMIZED controlled trials, Talbot George H, The Journal of antimicrobial chemotherapy, Thye Dirk A, Treatment Outcome, Treatment Outcomes
Does empiric therapy for atypical pathogens improve outcomes for patients with CAP?
Tags: 2013, Anti-Bacterial Agents/*therapeutic use, Antibiotic Prophylaxis, Antibiotics – Therapeutic Use, Clinical Trials, Clinical Trials as Topic, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Community-Acquired Infections/drug therapy/microbiology, Department of Internal Medicine, File Thomas M Jr, Humans, Infectious disease clinics of North America, Marrie Thomas J, NEOMED College of Medicine, Pneumonia – Drug Therapy, Pneumonia – Microbiology, Pneumonia/*drug therapy/microbiology
Case studies of lower respiratory tract infections: community-acquired pneumonia.
Tags: 2010, Acute – Microbiology, Adult, Adult/microbiology, Aged, Anti-Bacterial Agents/*therapeutic use, Antibiotics – Therapeutic Use, Antitubercular Agents – Therapeutic Use, Antitubercular Agents/therapeutic use, Community-Acquired Infections – Diagnosis, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections/diagnosis/drug therapy, Cough, Cough – Microbiology, Cough/microbiology/virology, Department of Internal Medicine, Diagnosis, Differential, Dyspnea, Fatal Outcome, Female, Fever – Microbiology, Fever/microbiology, File Thomas M Jr, Hemoptysis – Microbiology, Hemoptysis/microbiology, Human, Human – Complications, Human – Diagnosis, Human/complications/*diagnosis, Humans, Hypotension – Microbiology, Hypotension/microbiology, Influenza, Leukopenia – Microbiology, Leukopenia/microbiology, Male, Methicillin-Resistant Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus/*isolation & purification, Miliary/diagnosis/drug therapy, Multiple Organ Dysfunction Syndrome – Microbiology, Multiple Organ Failure/microbiology, Mycobacterium Tuberculosis, Mycobacterium tuberculosis/isolation & purification, NEOMED College of Medicine, Pneumonia – Diagnosis, Pneumonia – Drug Therapy, Pneumonia – Microbiology, Pneumonia – Therapy, Pneumonia/*diagnosis/*drug therapy/microbiology/therapy, Practice Guidelines, Practice Guidelines as Topic, Respiratory Distress Syndrome, Risk Factors, Severity of Illness Index, Severity of Illness Indices, Smoking, Smoking/adverse effects, Staphylococcal Infections – Diagnosis, Staphylococcal Infections – Drug Therapy, Staphylococcal Infections – Microbiology, Staphylococcal Infections – Therapy, Staphylococcal Infections/*diagnosis/*drug therapy/microbiology/therapy, The American journal of medicine, Tuberculosis, Tuberculosis – Diagnosis, Tuberculosis – Drug Therapy